DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado de Ciencias de la Salud
National Cancer Institute
Rockville, Estados UnidosPublicaciones en colaboración con investigadores/as de National Cancer Institute (8)
2023
-
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1605-1615
2022
-
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
Therapeutic Advances in Medical Oncology, Vol. 14
-
Cabozantinib for the treatment of solid tumors: a systematic review
Therapeutic Advances in Medical Oncology, Vol. 14
2020
-
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet, Vol. 395, Núm. 10241, pp. 1907-1918
-
Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)
European Urology
-
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†[Formula presented]: Under the Auspices of the EAU-ESMO Guidelines Committees
European Urology, Vol. 77, Núm. 2, pp. 223-250
2019
-
CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status
Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402
-
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
Annals of Oncology, Vol. 30, Núm. 11, pp. 1697-1727